WallStSmart

JBS N.V. (JBS)vsUSANA Health Sciences Inc (USNA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JBS N.V. generates 9882% more annual revenue ($91.17B vs $913.36M). JBS leads profitability with a 1.2% profit margin vs -2.4%. USNA earns a higher WallStSmart Score of 44/100 (D).

JBS

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 6.0Value: 6.0Quality: 6.0
Piotroski: 6/9Altman Z: 2.62

USNA

Hold

44

out of 100

Grade: D

Growth: 2.0Profit: 3.5Value: 6.0Quality: 7.3
Piotroski: 4/9Altman Z: 4.82

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JBS3 strengths · Avg: 8.7/10
Return on EquityProfitability
77.9%10/10

Every $100 of equity generates 78 in profit

P/E RatioValuation
12.5x8/10

Attractively priced relative to earnings

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

USNA3 strengths · Avg: 9.3/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
4.8210/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.688/10

Growing faster than its price suggests

Areas to Watch

JBS4 concerns · Avg: 2.3/10
Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Operating MarginProfitability
3.1%3/10

Operating margin of 3.1%

EPS GrowthGrowth
-57.2%2/10

Earnings declined 57.2%

Debt/EquityHealth
2.971/10

Elevated debt levels

USNA4 concerns · Avg: 2.5/10
Market CapQuality
$276.41M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.1%3/10

Operating margin of 4.1%

Return on EquityProfitability
-4.1%2/10

ROE of -4.1% — below average capital efficiency

Revenue GrowthGrowth
-5.3%2/10

Revenue declined 5.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : JBS

The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.8% demonstrates continued momentum.

Bull Case : USNA

The strongest argument for USNA centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.68 suggests the stock is reasonably priced for its growth.

Bear Case : JBS

The primary concerns for JBS are Profit Margin, Operating Margin, EPS Growth. Debt-to-equity of 2.97 is elevated, increasing financial risk. Thin 1.2% margins leave little buffer for downturns.

Bear Case : USNA

The primary concerns for USNA are Market Cap, Operating Margin, Return on Equity.

Key Dynamics to Monitor

JBS profiles as a value stock while USNA is a turnaround play — different risk/reward profiles.

JBS is growing revenue faster at 13.8% — sustainability is the question.

JBS generates stronger free cash flow (240M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

USNA scores higher overall (44/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JBS N.V.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.

USANA Health Sciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah.

Want to dig deeper into these stocks?